Clinical Genomics Pty Ltd. develops and delivers healthcare products for early detection and prevention of disease. The company is headquartered in North Ryde, Australia.

Alios is discovering and developing novel therapeutic agents based on three platform technologies including: small molecule activators of innate immunity antiviral pathways (RNase L activation), phosphate protected nucleotide prodrug chemistry, and glycoprotein-engineering of interferons (Glycoferonâ). This complementary group of platform technologies has the potential to generate a number of distinct therapeutic products to treat a variety of serious viral infections such as chronic hepatitis B and C, HIV infection, and respiratory viruses (e.g. pandemic influenza) and emerging viral diseases (e.g. SARS).

GENE DENOVO provides omics sequencing and bioinformatics analysis services. It is a genome sequencing, medical consultation, and health information management company. For inquiries, email, telephone numbers, and physical addresses are available on their website.

Guangzhou Medical University New Drug Creation Co., Ltd., established on 2015-08-21, Business scope includes medical research and experimental development;Biomedical Technology Research;Biotechnology Development Services;Biotechnology Transfer Services;drug development;Stem Cell Drug Development;Stem Cell Technology Research,to develop;Health Sciences Program Research Transfer;Technology intermediary service;Biological Products Testing;Clinical Laboratory Services;Manufacturing of chemical raw materials

Beijing Enze Kangtai Biotechnology Co., Ltd., established on 2017-06-01, Business scope includes technology development of exosomes,technical consulting,Technical Services,technology transfer;Medical Research and Experimental Development;Sales of chemical products(Free of Hazardous Chemicals).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

The Eli and Edythe L. Broad Institute of MIT and Harvard (/ˈbroʊd/), often referred to as the Broad Institute, is a biomedical and genomic research center located in Cambridge, Massachusetts, United States. The institute is independently governed and supported as a 501(c)(3) nonprofit research organization under the name Broad Institute Inc., and is partners with Massachusetts Institute of Technology, Harvard University, and the five Harvard teaching hospitals.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and the largest sequencing capacity in the world. Novogene utilizes scientific excellence, a commitment to customer service and unsurpassed data quality to help their clients realize their research goals in the rapidly evolving world of genomics. The company has become a world-leader in NGS services, with 1,800 employees and multiple locations across the globe. Novogene’s depth of experience has resulted in the ownership of 49 NGS-related patents, as well as the publishing of over 1850 customer research papers, often in well-respected publications such as Nature and Science. Company founder, Dr. Ruiqiang Li, is widely recognized as one of the world’s leading experts in genomics and bioinformatics, owning 12 patents and authoring over 90 peer-reviewed publications that have been cited >15,000 times. Best known for developing the software SOAP (Short Oligonucleotide Analysis Package) for ultra-fast sequence mapping, variation detection, and de novo genome assembly, Dr. Li has focused Novogene’s services on performing sequencing AND providing informatics to fully empower and enable their customers to move forward rapidly and effectively in their scientific endeavors.

Guangdong General Hospital (Chinese: 广东省人民医院 meaning "Guangdong Provincial People's Hospital") is a large hospital, founded in 1946, located in Yuexiu District, Guangzhou, Guangdong, China.

Lianchuan Bio is a bioinformatics and sequencing company. They provide life science and medical research customers with scientific research services and solutions. The company migrated application scenarios based on the accumulation of underlying gene technology and has gradually entered the clinical application field, independently developing innovative genetic testing medical devices.

Guangzhou Yeshan Biotechnology Co., Ltd., established on 2016-12-12, Business scope includes technical promotion of research results of health science projects,Life Engineering Project Development,Biotechnology Transfer Services,Health Sciences Program Research Transfer,Biotechnology Development Services,Human Science Research Achievement Transfer Service,Biotechnology Consulting,communication service,Chemical Reagent and Auxiliary Manufacturing(Monitor Chemicals,Excluding hazardous chemicals),Sales of chemical reagents and auxiliaries(Monitor Chemicals,Excluding hazardous chemicals),Sales of biological diagnostic reagents and kits(Does not include license approval items),Research and development of biodiagnostic reagents and kits(Does not include license approval items),Instrument wholesale

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women��s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer��s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ.

Shanghai Chest Hospital is a company headquartered in China ultimately controlled by the Government of China. The firm specializes in treating cadio-vascular system, lungs, esophagus, trachea and mediastinum.

Guangzhou Apparent Biotechnology Co., Ltd., established on 2016-11-08, Business scope includes biotechnology extension services;Medical Research and Experimental Development;Health Sciences Program Research,to develop;Biotechnology Development Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;Import and export(Excluding franchised products);Technology Import and Export;Conference and Exhibition Services;New material technology development service;New material technical consultation,communication service;Commodity wholesale trade(Except for licensed and approved products);Commodity retail trade(Except for licensed and approved products);